Evidence map›Paper›PMID 36426824›Full record

ArticleThe Journal of pathology2023

Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma.

Solange De Noon, Robert Piggott, Jamie Trotman, John A Tadross, Matthew Fittall, Debbie Hughes, Hongtao Ye, Emani Munasinghe, Matthew Murray, Roberto Tirabosco and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Fibroma of Tendon Sheath Revisited.In vivo (Athens, Greece)
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Solange De NoonResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-6380-8117
Robert PiggottCambridge Genomics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Jamie TrotmanCambridge Genomics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
John A TadrossCambridge Genomics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-8424-1252
Matthew FittallDepartment of Oncology, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-5172-4100
Debbie HughesPaediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK.
Hongtao YeDepartment of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.
Emani MunasingheDepartment of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.
Matthew MurrayDepartment of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-4480-1147
Roberto TiraboscoDepartment of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.
Fernanda AmaryDepartment of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK.
Nicholas ColemanDepartment of Pathology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-5374-739X
James WatkinsCambridge Genomics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Michael HubankClinical Genomics, The Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0002-2901-0742
Patrick TarpeyCambridge Genomics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Sam BehjatiDepartment of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-6600-7665
Adrienne M FlanaganResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-2832-1303
Royal National Orthopaedic Hospital · GBCambridge University Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GBInstitute of Cancer Research · GBRoyal Marsden NHS Foundation Trust · GBUniversity College London Hospitals NHS Foundation Trust · GB

Funding

Cancer Research UK 28990Department of HealthWellcome TrustWellcome Trust 223135/Z/21/Z
6 · The paper itself

Abstract

The FOS gene family has been implicated in tumourigenesis across several tumour types, particularly mesenchymal tumours. The rare fibrous tumour desmoplastic fibroblastoma is characterised by overexpression of FOSL1. However, previous studies using cytogenetic and molecular techniques did not identify an underlying somatic change involving the FOSL1 gene to explain this finding. Prompted by an unusual index case, we report the discovery of a novel FOSL1 rearrangement in desmoplastic fibroblastoma using whole-genome and targeted RNA sequencing. We investigated 15 desmoplastic fibroblastomas and 15 fibromas of tendon sheath using immunohistochemistry, in situ hybridisation and targeted RNA sequencing. Rearrangements in FOSL1 and FOS were identified in 10/15 and 2/15 desmoplastic fibroblastomas respectively, which mirrors the pattern of FOS rearrangements observed in benign bone and vascular tumours. Fibroma of tendon sheath, which shares histological features with desmoplastic fibroblastoma, harboured USP6 rearrangements in 9/15 cases and did not demonstrate rearrangements in any of the four FOS genes. The overall concordance between FOSL1 immunohistochemistry and RNA sequencing results was 90%. These findings illustrate that FOSL1 and FOS rearrangements are a recurrent event in desmoplastic fibroblastoma, establishing this finding as a useful diagnostic adjunct and expanding the spectrum of tumours driven by FOS gene family alterations. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Indexed as

FibromaFibroma, DesmoplasticSoft Tissue NeoplasmsGene RearrangementHumansIn Situ HybridizationUbiquitin ThiolesteraseUbiquitin ThiolesteraseUSP6 protein, humandesmoplastic fibroblastomaFOSFOSL1gene rearrangementtargeted sequencing

Identifiers

PMID36426824
PMCPMC10107450
OpenAlexW4310078128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.